Abstract
Chronic diarrhea is a common bowel disorder; disturbance of intestinal microorganisms may play a role in its pathogenesis. This study assessed the clinical efficacy of lyophilized, heat-killedLactobacillus acidophilus LB versus living lactobacilli in the treatment of chronic diarrhea. One hundred thirty-seven patients with chronic diarrhea were randomly allocated to receive either a 4-week course of 2 capsules of Lacteol® Fort twice a day (Lacteol group, 69 patients) or a 4-week course of 5 chewable tablets of Lacidophilin® three times a day (Lacidophilin group, 64 patients). The frequency of stools was recorded quantitatively, and semiquantitative parameters such as stool consistency, abdominal pain, distortion, and feeling of incomplete evacuation were evaluated. At the second and fourth week of treatment, mean bowel frequency was significantly lower in the Lacteol group than in the Lacidophilin group (1.88±1.24 vs 2.64±1.12, 1.39±0.92 vs 2.19±1.05; P<.05). At the end of the treatment, the clinical symptoms were markedly improved in the Lacteol group, indicating thatL. acidophilus LB is more effective than living lactobacilli in the treatment of chronic diarrhea.
Similar content being viewed by others
References
Locke GR III. The epidemiology of functional gastrointestinal disorders in North America.Gastroenterol Clin North Am. 1996;25:1–19.
Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders.Am J Epidemiol. 1992;136:165–177.
Fine KD, Schiller LR. AGA technical review on the evaluation and management of chronic diarrhea.Gastroenterology 1999;116:1464–1486.
Akehurst R, Kaltenthaler E. Treatment of irritable bowel syndrome: a review of randomised controlled trials.Gut. 2001;48:272–282.
Jones J, Boorman J, Cann P, et al. British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.Gut. 2000;47(suppl 2):ii1–19.
Altuntas B, Gul H, Yarali N, Ertan U. Etiology of chronic diarrhea.Indian J Pediatr. 1999;66:657–661.
Mehta DI, Lebenthal E, Blecker U. Chronic diarrhea: causes, presentation, and management.Indian J Pediatr. 1996;63:459–471.
Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health.J Nutr. 2000; 130(suppl 2S):396S-402S.
de Roos NM, Katan MB. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcino-genesis: a review of papers published between 1988 and 1998.Am J Clin Nutr. 2000;71:405–411.
Halpern GM, Prindiville T, Blankenburg M, Hsia T, Gershwin ME. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial.Am J Gastroenterol. 1996;91:1579–1585.
Bouloche JO, Mouterde O, Mallet E. Traitement des diarrhées aiguës chez le nourrisson et le jeune enfant. Etude contrôlée de l’activité antidiarrhéique deL. acidophilus tués (souche LB) contre un placebo et un médicament de référence (lopéramide).Annales de Pédiatrie. 1994; 41:457–463.
Simakachorn N, Pichaipat V, Rithipornpaisarn P, Kongkaew C, Tongpradit P, Varavithya W. Clinical evaluation of the addition of lyophilized, heat-killedLactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children.J Pediatr Gastroenterol Nutr. 2000;30:68–72.
Bodilis JY. Controlled clinical trial of Lacteol Fort compared with a placebo and reference drug in the treatment of acute diarrhea in the adult.Medecine Actuelle. 1983;10:232–235.
Shornikova AV, Casas IA, Mykkanen H, Salo E, Vesikari T. Bacteriotherapy withLactobacillus reuteri in rotavirus gastroenteritis.Pediatr Infect Dis J. 1997;16:1103–1107.
Shornikova AV, Casas IA, Isolauri E, Mykkanen H, Vesikari T.Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children.J Pediatr Gastroenterol Nutr. 1997;24:399–404.
Guandalini S, Pensabene L, Zikri MA, et al.Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial.J Pediatr Gastroenterol Nutr. 2000;30:54–60.
Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis.J Pediatr Gastroenterol Nutr. 1995;20:333–338.
Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A humanLactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children.Pediatrics. 1991;88:90–97.
Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria.J Dairy Sci. 1995;78:491–497.
Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a humanLactobacillus strain.Pediatr Res. 1992;32:141–144.
Chauviere G, Coconnier MH, Kernels S, Fourniat J, Servin AL. Adhesion of humanLactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells.J Gen Microbiol. 1992;138(pt 8): 1689–1696.
Chauviere G, Coconnier MH, Kernels S, Darfeuille-Michaud A, Joly B, Servin AL. Competitive exclusion of diarrheagenicEscherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus.FEMS Microbiol Lett. 1992;70:213–217.
Coconnier MH, Bernet MF, Kerneis S, Chauviere G, Fourniat J, Servin AL. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells byLactobacillus acidophilus strain LB decreases bacterial invasion.FEMS Microbiol Lett. 1993;110:299–305.
Coconnier MH, Bernet MF, Chauviere G, Servin AL. Adhering heat-killed humanLactobacillus acidophilus, strain LB, inhibits the process of pathogenicity of diarrheagenic bacteria in cultured human intestinal cells.J Diarrheal Dis Res. 1993;11:235–242.
Coconnier MH, Lievin V, Bernet-Camard MF, Hudault S, Servin AL. Antibacterial effect of the adhering humanLactobacillus acidophilus strain LB.Antimicrob Agents Chemother. 1997;41: 1046–1052.
Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a humanLactobacillus strain.Antimicrob Agents Chemother. 1987;31:1231–1233.
Coconnier MH, Lievin V, Lorrot M, Servin AL. Antagonistic activity ofLactobacillus acidophilus LB against intracellularSalmonella enterica serovarTyphimurium. infecting human enterocyte-like Caco-2/TC-7 cells.Appl Environ Microbiol. 2000;66:1152–1157.
Coconnier MH, Lievin V, Hemery E, Servin AL. Antagonistic activity againstHelicobacter infection in vitro and in vivo by the humanLactobacillus acidophilus strain LB.Appl Environ Microbiol. 1998;64:4573–4580.
Canducci F, Armuzzi A, Cremonini F, et al. A lyophilized and inactivated culture ofLactobacillus acidophilus increasesHelicobacter pylori eradication rates.Aliment Pharmacol Ther. 2000;14: 1625–1629.
Sussman JI, Baron EJ, Goldberg SM, Kaplan MH, Pizzarello RA. Clinical manifestations and therapy ofLactobacillus endocarditis: report of a case and review of the literature.Rev Infect Dis. 1986;8:771–776.
Harty DW, Oakey HJ, Patrikakis M, Hume EB, Knox KW. Pathogenic potential of lactobacilli.Int J Food Microbiol. 1994;24:179–189.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xiao, SD., De Zhang, Z., Lu, H. et al. Multicenter, randomized, controlled trial of heat-killedLactobacillus acidophilus LB in patients with chronic diarrhea. Adv Therapy 20, 253–260 (2003). https://doi.org/10.1007/BF02849854
Issue Date:
DOI: https://doi.org/10.1007/BF02849854